patients

Care D. 6. Glycemic targets: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S61–70. MathSciNet  Google Scholar  Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, …

This technology automates the release of insulin into the bloodstream [Getty Images] Tens of thousands of people with type 1 diabetes in the UK are to be given a new …

Medscape “Making the invisible visible”: CGM provides insight into T2D. Several studies of continuous blood glucose monitoring in patients with type 2 diabetes have shown improvements in clinical parameters. …3 …

specialty Please chooseI’m not a medical professional.Allergy and immunologyanatomyanesthesiologyCardiac, thoracic, and vascular surgerycardiologyCritical caredentalDermatologyDiabetes and endocrinologyemergency medical careepidemiology and public healthRegular medicineForensic medicineDepartment of GastroenterologyGeneral medical treatmentgeneticsgeriatric medicinemedical policyHematologyHIV/AIDShospital-based medical …

Glucagon-like peptide 1 (GLP-1) receptor agonists are the latest blockbuster drugs thanks to their powerful ability to help patients lose weight. But shortages are expected to last until the end …

Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet (London, England). 2022;400(10365):1803–20. Article  PubMed  Google Scholar  IDF diabetes Atlas. 9th edn. Brussels, Belgium: International Diabetes …

This study showed that 90.41%, 8.93%, and 0.66% of the subjects had diabetes-related knowledge scores of less than 60 points, 60-79 points, and 80 points or more, respectively, indicating the …

Piette, J. D. & Kerr, E. A. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 29, 725–731 (2006). Article  PubMed  Google Scholar  Schabert, J., Browne, J. L., …

Understanding diabetes, a common chronic disease in adults over 65, and its impact on quality of life (QoL) may reduce the burden on health and lead to better management and …

1. The risk of cardiovascular disease (CVD) and all-cause mortality in patients with type 2 diabetes mellitus (T2DM) is increased in patients with nonalcoholic fatty liver disease (NAFLD). compared with …